Providence Capital Advisors, LLC Bausch Health Companies Inc. Transaction History

Providence Capital Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$25.04 - $30.06 $29,422 - $35,320	-1,175 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$27.43 - $32.7 $3,428 - $4,087	125 Added 11.9%	1,175 $34,000
Q1 2021 May 13, 2021	SELL	$21.37 - $34.38 $86,548 - $139,239	-4,050 Reduced 79.41%	1,050 $33,000
Q4 2020 Feb 11, 2021	SELL	$15.31 - $21.12 $21,434 - $29,568	-1,400 Reduced 21.54%	5,100 $106,000
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $58,032 - $78,507	3,900 Added 150.0%	6,500 $101,000
Q2 2020 Aug 04, 2020	BUY	$13.31 - $20.51 $6,655 - $10,255	500 Added 23.81%	2,600 $48,000
Q1 2020 May 12, 2020	BUY	$12.98 - $30.25 $14,278 - $33,275	1,100 Added 110.0%	2,100 $33,000
Q4 2019 Feb 13, 2020	SELL	$18.89 - $31.89 $18,890 - $31,890	-1,000 Reduced 50.0%	1,000 $30,000
Q3 2019 Nov 13, 2019	BUY	$20.88 - $25.66 $20,880 - $25,660	1,000 Added 100.0%	2,000 $44,000
Q2 2019 Aug 13, 2019	SELL	$20.52 - $26.45 $20,520 - $26,450	-1,000 Reduced 50.0%	1,000 $25,000
Q1 2019 May 08, 2019	BUY	$20.23 - $26.29 $40,460 - $52,580	2,000 New	2,000 $49,000

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.69B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Providence Capital Advisors, LLC with notifications on news.